Who is sponsoring NCT04211051?

NCT04211051 is sponsored by Ruijin Hospital.

What drugs are being tested in NCT04211051?

Interventions in NCT04211051: LungBrella marker implantation and VATS partial lobe resection.

What condition does NCT04211051 study?

NCT04211051 studies Lung Neoplasms.

Is NCT04211051 still recruiting?

NCT04211051 is currently completed. Last updated 31 August 2021.

Last reviewed 2021-08-31 · How we verify

NCT04211051

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Feasibility of Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules

Completed NA Last updated 31 August 2021

What this trial tests

NA trial testing LungBrella marker implantation and VATS partial lobe resection in Lung Neoplasms in 10 participants. Completed in 21 October 2020.

Timeline

15 April 2020

Primary endpoint
21 October 2020

21 October 2020

Quick facts

Lead sponsor	Ruijin Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	15 April 2020
Primary completion	21 October 2020
Estimated completion	21 October 2020
Sites	1 location across China

Drugs / interventions tested

LungBrella marker implantation and VATS partial lobe resection

Conditions studied

Lung Neoplasms — all drugs for Lung Neoplasms →

Sponsor

Ruijin Hospital

Who can join

Adults 18 to 70, any sex, with Lung Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

As the detection of small pulmonary nodules continuously grows, the intraoperative localization of small pulmonary nodules is in great demand. The intraoperative localization nowadays is usually done under local anesthesia before surgery. There is a certain rate of failure and complication. The result of our early animal experiments show that the pulmonary surgery marker system can deliver the intraoperative localization safely and precisely under anesthesia, and the average distance between the localization and the simulated lesion is less than 5mm during surgery. Therefore, the safety and feasibility of the system require further evaluation in patients

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Augmented reality navigation-guided pulmonary nodule localization in a canine model.
Li C, Zheng Y, Yuan Y, Li H. · · 2021 · cited 10× · PMID 35004246 · DOI 10.21037/tlcr-21-618
Augmented reality navigation-guided intraoperative pulmonary nodule localization: a pilot study.
Li C, Ji A, Jian Z, Zheng Y, et al · · 2023 · cited 9× · PMID 37691871 · DOI 10.21037/tlcr-23-201

Verify or expand the search:

Other trials of LungBrella marker implantation and VATS partial lobe resection

Trials testing the same drug.

NCT04529603 — The Efficacy of Intraoperative Pulmonary Nodules Localization Guided by Virtual Reality Technology · NA · withdrawn

Other recruiting trials for Lung Neoplasms

Currently open trials in the same condition.

NCT07476287 — Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult · Phase 2 · recruiting
NCT07509333 — MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients · NA · recruiting
NCT07109154 — DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First- · recruiting
NCT06974604 — Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM · Phase 2 · recruiting
NCT07165691 — TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics · NA · recruiting

Other Ruijin Hospital trials

Trials by the same sponsor.

NCT07589361 — Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors · not yet recruiting
NCT07449507 — Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy · NA · not yet recruiting
NCT07496385 — Clinical Study on the Efficacy of Subglottic Suction in Mechanically Ventilated Patients Guided by Bedside Ultrasound · NA · not yet recruiting
NCT07511114 — A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyp · Phase 3 · not yet recruiting
NCT07514169 — The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04211051 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ruijin Hospital
Last refreshed: 31 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04211051.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing